UBS Group’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
627,719
+229,576
| +58% | +$4.16M | ﹤0.01% | 2317 |
|
|
2025
Q1 | $8.15M | Buy |
398,143
+317,933
| +396% | +$6.51M | ﹤0.01% | 2552 |
|
|
2024
Q4 | $2.06M | Sell |
80,210
-50,030
| -38% | -$1.29M | ﹤0.01% | 3691 |
|
|
2024
Q3 | $2.16M | Buy |
130,240
+124,171
| +2,046% | +$2.06M | ﹤0.01% | 2964 |
|
|
2024
Q2 | $117K | Sell |
6,069
-42,210
| -87% | -$811K | ﹤0.01% | 4950 |
|
|
2024
Q1 | $1.14M | Buy |
48,279
+47,479
| +5,935% | +$1.12M | ﹤0.01% | 3454 |
|
|
2023
Q4 | $8.94K | Buy |
+800
| New | +$8.94K | ﹤0.01% | 6311 |
|
|
2023
Q3 | – | Sell |
-183
| Closed | -$2.18K | – | 8558 |
|
|
2023
Q2 | $2.18K | Buy |
+183
| New | +$2.18K | ﹤0.01% | 6716 |
|